COVID-19 cases in India are increasing. Agra heaves a sigh of relief as the recovery rate touched 80. The total count stands at 837, of which 696 have recovered and the number of active cases is now 110.
A new UT Southwestern study shows how an effective but largely abandoned treatment for Type 2 diabetes named Rosiglitazone, could be used again in combination with another drug to eliminate side effects.
COVID-19 vaccine trial with two antimalarial drugs - chloroquine and hydroxychloroquine has begun in the UK's Brighton and Oxford. The trial is open to anyone delivering direct care to coronavirus patients in the UK.
Emergency vaccine for coronavirus (COVID-19) can be ready by next January or February. mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration.
The Indian Council of Medical Research has laid out guidelines for Do Not Attempt Resuscitation (DNAR) and Cardiopulmonary resuscitation (CPR) protocols, thereby redefining end-of-life care practices in the country.
Oxford University has reported positive findings from preclinical animal studies of its potential COVID-19 vaccine ChAdOx1, which involved nine rhesus macaques. However, results from human clinical trials are expected next month.